Skip to content
Catalyst

OutcomesOutcome

Total nasal symptom score (TNSS)

1 finding from 1 compound ↓reported in points (total score)

Total nasal symptom score (TNSS)

1 finding · 1 compound · 1 null · by evidence strength. No dose is advised.

Fig. 2 Total nasal symptom score (TNSS)1 compound outer ring on requestSelected Total nasal symptom score (TNSS) · centre
×1.60
Labels
Measured outcomeInspector

Total nasal symptom score (TNSS)

Findings drawn, by strength

1finding · 1 compound

  • Moderate1
Keys

← → round a ring↑ ↓ out and inEnter selecte the outer ringf fit to view+ − zoomEsc clearclick a node to select it

Compound no difference foundFindingsStrongest
1
Moderate

Not pooled · no summary effect · point at a mark · Tab, then the arrow keys

Measured, no difference found1 finding

  1. N-hexadecanoylethanolamineMoved: no difference foundEvidence: ModeratePaper: PMID 380687972023
    Who
    Adults aged 21 to 77 years with seasonal allergic rhinitis, 108 randomised and 101 completed; whole-population comparison, reflective total nasal symptom score recorded online twice daily
    Dose studied
    Levagen+ (PEA) 350 mg daily, two 175 mg capsules each morning, against placebo of 175 mg maltodextrin per capsule

    No significant difference was seen between the Levagen+ and placebo groups for the allergy symptoms scores (rTNSS) at baseline or throughout the 14 days of treatment.”

    Quoted verbatim from The Effect of Levagen+ (Palmitoylethanolamide) Supplementation on Symptoms of Allergic Rhinitis-A Double-Blind Placebo-Controlled Trial.RCT · 14 daysPermalink

How it is measured

Total Nasal Symptom Score, the sum of participant-rated severity of the nasal symptoms of allergic rhinitis (blocked or obstructed nose, runny nose or secretion, itching nose, sneezing), each rated on a 4-point scale, self-reported. Whether the score was taken under natural allergen exposure, in an allergen exposure chamber or after nasal allergen provocation, the recall period, and the number of items summed are recorded with each finding.

Papers about it

As an endpoint1

Show the paperHide the paper
  • The Effect of Levagen+ (Palmitoylethanolamide) Supplementation on Symptoms of Allergic Rhinitis-A Double-Blind Placebo-Controlled Trial.

    Nutrients2023PMID 38068797Via: named in the paper, as read